Given that oncogenic K-ras mutations co-exist with p65NFκB over expression in A549 cells [38]65, we postulated that K-ras/NFκB axis might be an important target to curb migration in these NSCLC cells. Here, KRAS is linked to non-small cell lung carcinoma.